谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Proteomic and Metabolomic Features in Patients with HCC Responding to Lenvatinib and Anti-Pd1 Therapy

Zhong-Chen Li,Jie Wang,He-Bin Liu,Yi-Min Zheng,Jian-Hang Huang,Jia-Bin Cai,Lei Zhang,Xin Liu,Ling Du, Xue-Ting Yang,Xiao-Qiang Chai,Ying-Hua Jiang,Zheng-Gang Ren,Jian Zhou,Jia Fan,De-Cai Yu,Hui-Chuan Sun,Cheng Huang,Feng Liu

Cell Reports（2024）

引用 1|浏览22
关键词
hepatocellular carcinoma,PD1,lenvatinib,proteomics,metabolomics,complement,lysophosphatidylcholine,immunotherapy,combination therapy,machine learning
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要